GPT Analysis

Empower Your Investments! Unleash the Potential with Smart Stock Analysis!

United States Hong Kong China Singapore Japan India
Sorting Arrows
Symbol
▲ ▼
Company Name Rating
▲ ▼
Recommendation
▲ ▼
Evaluation from GPT Action Time
▲ ▼
A Agilent Technologies Inc 40 Negative A is a stock listed on the NYSE with a market capitalization of $31.74 billion. The stock has a 52-week high of $160.26 and a 52-week low of $96.80. The current price is $108.47, which is close to the 52-week low. The stock has a negative year change of -25.90%. The 200-day average is $125.72, indicating a downward trend. The stock's trading volume is relatively low, with an average of 1,970,256 shares traded over the past three months. Based on these indicators, the stock does not seem to be performing well and may not be a good investment option at the moment.

2023-11-13 02:35:51
AA Alcoa Corp 60 Negative Alcoa Corporation (AA) is a leading aluminum producer in the Basic Materials sector. The company has a market capitalization of $5.06 billion and operates with 13,100 full-time employees. AA has a strong governance and risk profile, with low overall risk and high shareholder rights. However, it has negative profit margins and a high debt-to-equity ratio of 28.399, indicating financial challenges. The stock has a beta of 2.46473, making it more volatile than the market. AA's current price of $28.35 is below its 52-week high of $57.609, and its forward P/E ratio of 9.145162 suggests it may be undervalued. The average analyst rating is 'hold' with a target mean price of $37.81. Considering the company's financial challenges and industry volatility, it is recommended to approach investing in AA with caution.

2023-09-24 06:39:34
AAC Ares Acquisition Corporation - Class A 20 Negative Ares Acquisition Corporation (AAC) is a shell company operating in the financial services sector. With a market capitalization of $760 million, AAC has been trading between a 52-week range of $9.84 and $10.60. The stock's beta of 0.0116 indicates low volatility compared to the overall market. AAC's financial indicators are not very favorable, with negative trailing EPS of -$0.07 and a forward EPS estimate of -$1.01. Additionally, the company has a negative return on assets (-0.91%) and no profit margins. The average trading volume is low at 138,150 shares over the past 10 days, further indicating limited investor interest.

Considering the lack of positive financial performance and the speculative nature of shell companies, it is not recommended to invest in AAC at this time. The stock receives a rating of 20 out of 100, indicative of poor prospects. The sentiment is negative, suggesting caution.

2023-07-19 17:51:59
AAC-WS Ares Acquisition Corporation - Warrants (01/01/9999) 0 Negative Based on the provided financial indicators, it appears that AAC-WS does not have sufficient data available for analysis. The trailingPegRatio is not provided, and the quoteType is listed as NONE. Without these key indicators, it is difficult to assess the investment potential of AAC-WS. It is recommended to gather more information on the stock or consult with a financial advisor before making any investment decisions.

2023-10-23 00:10:14
AACG ATA Creativity Global 40 Negative ATA Creativity Global (AACG) operates in the education and training services industry. The company has experienced negative profit margins, revenue growth below industry average, negative earnings per share and negative returns on assets and equity. These factors indicate weakness in the company's financial performance. However, the company has a high target price compared to its current market price and analyst recommendations indicate a strong buy. The company has a strong cash position and low debt to equity ratio, which could help it weather short-term financial challenges. Overall, investment in AACG is risky and requires careful analysis of the company's future prospects.

2023-06-24 08:53:01
AACI Armada Acquisition Corp I 20 Negative Armada Acquisition Corp. I (AACI) is a shell company in the financial services sector. The company's financial indicators show a lack of significant activity and profitability, with a negative trailing EPS and net income. Additionally, the company's book value is negative, indicating potential financial instability. The stock has a low trading volume, which further reflects limited investor interest.

Considering these factors, it is difficult to determine the potential for growth or value in investing in AACI. It would be prudent to look for other investment options with better financial performance and stability.

2023-07-02 03:33:53
AACIU Armada Acquisition Corp I - Units (1 Ord & 1/2 War) 0 Negative Based on the financial indicators provided, it is important to note that AACIU is a shell company with no reported financial activity or trading volume. The lack of financial data and market activity makes it difficult to assess the investment potential of AACIU. Additionally, the company has negative book value, negative earnings per share, and negative return on assets. These factors indicate a lack of profitability and financial stability. Therefore, it is not recommended to invest in AACIU due to the lack of information and unfavorable financial indicators.

2023-07-28 05:39:09
AADI Aadi Bioscience Inc 40 Negative Aadi Bioscience, Inc. (AADI) is a biotechnology company specializing in the healthcare sector. With a focus on developing innovative therapies, AADI has 80 full-time employees and operates in the biotechnology industry. The company has a market cap of $142,223,344 and is listed on the NCM exchange.

Despite showing signs of growth potential, AADI has a negative trailing EPS of -2.59 and a negative forward EPS of -2.71. The company's revenue growth rate is positive at 1.543, but its gross margins are negative. AADI also has a high board risk and compensation risk, which should be considered.

Based on the financial indicators and historical data, it is advised to exercise caution when considering AADI as an investment. The company's overall risk rating of 8 further supports this cautious stance. It is recommended to conduct further research and evaluation before making any investment decisions.

2023-07-25 01:52:47
AAMC Altisource Asset Management Corp 18 Negative Altisource Asset Management Corp (AAMC) is a company that specializes in providing private credit, particularly in underserved markets. However, the company has faced challenges in recent years, with a significant decline in its stock price. The stock currently trades at a year low of $2.64, which is significantly lower than its year high of $60.88. The company's financial indicators also raise concerns, with a two hundred day average of $20.54, indicating a significant downward trend. With a year change of -0.73, it is evident that AAMC has struggled in the market. Additionally, the stock has a negative sentiment, as reflected in the negative rating. Considering these factors, it is advisable to avoid investing in AAMC at this time.

2024-01-21 13:45:41
AAME Atlantic American Corp 40 Negative Atlantic American Corporation (AAME) is an insurance company headquartered in the United States that specializes in life insurance. AAME is currently trading at $2.11 per share. While AAME has shown some growth in revenue and profit margins, it is currently trading below its 52-week high and experiencing a negative return on assets. Additionally, the insurance sector as a whole has experienced some challenges due to COVID-19 and the economic downturn. Consider additional research and market analysis prior to making an investment decision.

2023-06-24 15:26:12
AAN Aarons Company Inc (The) 60 Negative The Aaron's Company, Inc. (AAN) is a rental and leasing services company in the industrials sector. It operates in the United States with over 10,060 full-time employees. AAN has a market capitalization of $442,921,664 and a beta of 1.01, indicating moderate volatility. The stock has been trading in a range of $7.65 to $16.61 over the past year.

AAN's financial indicators show some concerns. The company has negative profit margins (-0.60%) and negative earnings growth (-40.6%). However, the company has strong revenue growth (21.5%) and gross margins (50.9%). The current ratio of 3.55 indicates a healthy liquidity position.

The stock is currently trading at $14.33, with a 52-week target range of $9.30 to $18.00. The average volume over the past 10 days is 413,000 shares.

Considering the financial indicators and the stock's performance, the sentiment for AAN is 'Negative'.

Based on the analysis, the rating for AAN is 60, indicating an average investment opportunity. Investors should further evaluate the company's financial performance, profitability, and industry trends before making a decision.

2023-06-30 06:29:53
AAPD Direxion Daily AAPL Bear 1X Shares 45 Negative Direxion Daily AAPL Bear 1X Shares (AAPD) is an exchange-traded fund (ETF) that aims to provide daily investment results, before fees and expenses, that correspond to the inverse (-1x) of the daily performance of the S&P 500 Information Technology Index. As of the last available data, the fund's net asset value (NAV) is $20.545 per share.

2023-06-30 06:29:51
ACABU Atlantic Coastal Acquisition Corp II - Units (1 Ord Class A & 1/2 War) 20 Negative Based on the financial indicators provided, it appears that Atlantic Coastal Acquisition Corp. II (ACABU) is not a good investment option. The company has very low trading volumes and does not seem to have any positive financial indicators, such as high earnings or a low debt-to-equity ratio. Furthermore, the company has not paid dividends and has a negative book value, which suggests that its assets are less than its liabilities. Although the stock has experienced a slight increase in the past year, this is not necessarily indicative of future performance. It is therefore recommended to avoid investing in ACABU at this time.

2023-06-27 19:28:07
ACAC Acri Capital Acquisition Corp - Class A 20 Negative Acri Capital Acquisition Corporation (ACAC) is a shell company in the Financial Services sector. It has a market capitalization of $62,407,356 and a trailing P/E ratio of 107.6. ACAC's stock price has shown some stability, with a fifty-two-week range between $9.97 and $10.93. The company does not pay dividends. ACAC has a low volume of 5,955 shares traded, which may indicate limited investor interest. The financial indicators, such as profit margins and net income, are not available or are zero. ACAC's financials present a high level of risk and uncertainty, making it less attractive for investment opportunities. Therefore, the sentiment towards ACAC is Negative, and its rating is 20 out of 100, indicating a poor investment choice.

2023-07-13 14:47:28
ACACU Acri Capital Acquisition Corp - Units (1 Ord Class A & 1/2 War) 50 Negative Based on the provided financial indicators for ACACU, it is difficult to make a definitive recommendation on the stock. ACACU is a shell company in the financial services sector, and it has not yet commenced its operations. The company has no profit margins, and it reported negative book value. Furthermore, its operating cashflow is negative. These factors indicate high-risk and uncertainty surrounding the company's future prospects. The stock has a low average volume and limited trading activity. Additionally, there is no available dividend information. Given the lack of data on the company's performance and potential, it is advisable to approach investing in ACACU with caution.

2023-07-13 14:50:37
ACON Aclarion Inc 20 Negative Aclarion, Inc. (ACON) is a health information services company operating in the Healthcare sector. The company has a market capitalization of $5,796,382 and operates with 7 full-time employees. ACON provides health information services, but it currently has negative profit margins, indicating losses. Although the company's revenue has shown growth of 88% in the past year, it has gross profit and operating margins in the negative, which is concerning. ACON has a high price-to-sales ratio of 95.90, indicating an overvaluation. Additionally, the company has a negative forward price-to-earnings ratio of -2.44. The stock's performance has seen a significant decline with a 52-week change of -19.66%. The average daily trading volume is relatively low at 87,600 shares. Considering these factors, it is recommended to avoid investing in ACON, as the stock's prospects do not appear favorable at the moment.

2023-07-05 13:29:27
ADMP Adamis Pharmaceuticals Corp 20 Negative Adamis Pharmaceuticals Corporation (ADMP) is a pharmaceutical company specializing in the development and commercialization of therapeutic products. While ADMP has a high beta of 1.21, indicating higher volatility compared to the market, the stock has significantly declined over the past year, with a 52-week change of -92.8%. The company's financials are concerning, with negative earnings per share and a negative return on equity. Additionally, its gross margins and operating margins are both negative, suggesting operational challenges or inefficiencies. ADMP's debt levels are relatively low compared to its total cash, which provides some stability. However, the company's revenue growth has been positive but modest. Considering these factors, it's difficult to recommend investing in ADMP at this time. The sentiment is negative, and the rating is 20 out of 100.

2023-08-04 08:19:22
ADSE Ads-Tec Energy Plc 40 Negative ADS-TEC Energy PLC (ADSE) is an electrical equipment and parts company based in Ireland. The company has 189 full-time employees and operates in the industrials sector. ADSE's stock price has shown volatility, with a 52-week range of $1.905 to $8.71. The current price is $7.39. The company's financial indicators reveal a negative profit margin of -0.72% and negative trailing EPS of -0.47. ADSE's revenue growth has been positive at 40.6%, but the gross margins and operating margins are negative. The company has a high debt-to-equity ratio of 4.306, indicating a higher level of financial risk. ADSE's average daily trading volume is 29,470 shares. Based on these factors, the sentiment for ADSE is Negative, and the rating is 40 out of 100.

2023-08-17 13:23:15
ALEX Alexander & Baldwin Inc 40 Negative Alexander & Baldwin, Inc. is a Real Estate Investment Trust (REIT) that specializes in retail properties. The company has recently reported negative earnings growth and revenue growth, as well as negative profit margins. The company's debt to equity ratio is quite high, indicating that the company has relatively high levels of debt. The company has a trailing PE ratio of 36.14, which is higher than the industry average. Additionally, the company's dividend yield is not particularly high, and may not justify investing in the stock purely for its dividend. However, the company has strong institutional ownership and has a target mean price of $21.00.

2023-06-24 15:29:42
ALL Allstate Corp (The) 60 Negative Based on the provided financial indicators, the stock of ALL (Allstate Corporation) appears to be in a negative trend. The stock's price has been volatile, with a significant drop from the fiftyTwoWeekHigh of $142.15 to a dayLow of $100.97. The dividend yield of 3.52% seems attractive, but it is essential to consider the overall performance of the stock. The forward PE ratio of 7.97 suggests that the market has lower growth expectations for the company. Furthermore, the trailing PEG ratio is not available, making it challenging to evaluate the stock's potential growth prospects. The average volume and market cap are relatively stable, indicating a moderate level of investor interest. In conclusion, given the overall negative trend and uncertain growth prospects, it is advisable to approach this investment with caution.

2023-07-15 21:17:02